Company Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States and internationally.
The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing (AST) of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.
It also provides Accelerate PhenoTest BC Kit, a test kit for the system, which is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.
In addition, the company offers Accelerate Arc system, an instrument and associated one-time-use test kit that automates the clean-up and concentration of microbial cells from positive blood culture samples.
Further, it develops Accelerate WAVE system, which performs AST directly from positive blood culture bottles and bacterial isolate colonies to report minimum inhibitory concentrations.
The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012.
Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
| Country | United States |
| Founded | 1982 |
| IPO Date | Nov 18, 1996 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 107 |
| CEO | Jack Phillips |
Contact Details
Address: 3950 South Country Club Road, Suite 470 Tucson, Arizona 85714 United States | |
| Phone | 520 365 3100 |
| Website | acceleratediagnostics.com |
Stock Details
| Ticker Symbol | AXDX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000727207 |
| CUSIP Number | 00430H102 |
| ISIN Number | US00430H2013 |
| Employer ID | 84-1072256 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Jack Phillips | Chief Executive Officer, President and Director |
| David Patience | Chief Financial Officer |
| Lawrence Michael Mertz | Chief Technology Officer |
| Maya Gowri | Senior Vice President and Head of Operations |
| Laura Pierson | Investor Relations Officer |
| John Meduri | Chief Strategy Officer |
| Chris Thode | Senior Vice President of US Commercial |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2025 | 8-K | Current Report |
| Apr 15, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 10-K | Annual Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 6, 2025 | SCHEDULE 13D/A | Filing |
| Jan 30, 2025 | 8-K | Current Report |
| Jan 10, 2025 | 8-K | Current Report |
| Jan 7, 2025 | SCHEDULE 13G/A | Filing |